My research is focused on making effective use of alternative types of biological effects data—for instance, high-throughput toxicity data that measures and characterizes biological changes in response to chemical exposures—using what are known as Adverse Outcome Pathways (AOPs). AOPs are conceptual frameworks that describe how an organism responds, on a molecular and cellular level, when first exposed to a toxic chemical and connect that response to adverse effects that are of regulatory significance.